Intraovarian platelet-rich plasma administration could improve blastocyst euploidy rates in women undergoing in vitro fertilization

OBJECTIVE: Platelet-rich plasma (PRP) therapy has received a considerable attention as an adjunct to fertility treatments, especially in women with very low ovarian reserve and premature ovarian insufficiency. Although recent studies have demonstrated that PRP led to improvements in folliculogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Merhi, Zaher, Seckin, Serin, Mouanness, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Reproductive Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468693/
https://www.ncbi.nlm.nih.gov/pubmed/36097737
http://dx.doi.org/10.5653/cerm.2021.05057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468693/
https://www.ncbi.nlm.nih.gov/pubmed/36097737
http://dx.doi.org/10.5653/cerm.2021.05057

Ejemplares similares